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Summary: HIV-infected mothers and newborns had lower percentage seropositivity and 
antibody titers to influenza A viruses than HIV-uninfected mothers. Placental malaria had no 
impact on infant seropositivity. Transplacental transfer of influenza antibodies was not impaired 
by maternal HIV or placental malaria. 
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Abstract  
Background. Maternal influenza vaccination protects infants against influenza virus infection. 
Impaired transplacental transfer of influenza antibodies may reduce this protection.  
Methods. We conducted a cross-sectional study of influenza vaccine-naïve pregnant women 
recruited at delivery from Blantyre (urban, low malaria transmission) and Chikwawa (rural, 
high malaria transmission) in Southern Malawi. HIV-infected mothers were excluded in 
Chikwawa. Maternal and cord blood antibodies against circulating influenza strains 
A/California/7/2009, A/Victoria/361/2011, B/Brisbane/60/2008 and B/Wisconsin/1/2010 were 
measured by hemagglutination inhibition (HAI). We studied the impact of maternal HIV 
infection and placental malaria on influenza antibody levels in mother-infant pairs in Blantyre 
and Chikwawa, respectively. 
Results. We included 454 mother-infant pairs (Blantyre, n=253; Chikwawa, n=201). HIV-
infected mothers and their infants had lower seropositivity (HAI titer >1:40) against influenza 
A(H1N1)pdm09 (mothers, 24.3 vs. 45.4%, p=0.02; infants 24.3 vs. 50.5%, p=0.003) and 
A(H3N2) (mothers, 37.8% vs. 63.9%, p=0.003; infants 43.2 vs. 64.8%, p=0.01), whereas 
placental malaria had inconsistent effect on maternal and infant seropositivity. In multivariable 
analyses, maternal HIV infection was associated with reduced infant seropositivity 
(A(H1N1)pdm09 aOR 0.34, 95%CI 0.15-0.79; A(H3N2) aOR 0.43, 95%CI 0.21-0.89). 
Transplacental transfer was not impaired by maternal HIV or placental malaria. 
Discussion. Maternal HIV infection influenced maternal antibody response to influenza A 
virus infection and therefore antibody levels in newborns, but did not affect transplacental 
antibody transfer.  
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Introduction 
 
Pregnant women and infants under 6 months are at increased risk of severe influenza 
complications [1]. During the 2009 influenza A(H1N1) pandemic, pregnant women had higher 
rates of hospital and intensive care admissions [2, 3], as well as a 5-fold risk of death [4], 
compared to non-gravid women. Some studies of pregnancy outcomes have suggested 
increased risk of pregnancy complications attributable to maternal influenza illness; others 
have not [5]. The World Health Organization (WHO) designated pregnant women as the 
highest priority for influenza vaccination [6], though few low- and middle-income countries 
have vaccination programs targeted at pregnant women [7]. 
Recent randomised trials have shown that influenza vacci ation in pregnancy not only protects 
the mother but also young infants against influenza and its complications [8, 9]. This is partly 
due to the reduced risk of maternal infection and transmission to the infant, and also through 
the active transplacental transfer of maternal antibodies generated from immunization [10]. 
The latter is crucial for infants <6 months, who have higher rates of influenza-associated 
hospitalization [11] but are ineligible to receive influenza vaccines [12]. 
HIV infection and malaria are prevalent in sub-Saharan Africa; maternal HIV infection and 
placental malaria have been associated with impaired transplacental transfer of maternal 
antibodies against a number of vaccine-preventable diseases including tetanus, measles and 
Streptococcus pneumoniae [13-16]. HIV-infected pregnant women are an important target 
group for influenza vaccination since HIV-infected adults [17] and pregnant women [18] have 
greater risk of severe influenza, while the impact of malaria co-infection is poorly studied [19]. 
Before implementing maternal influenza vaccination in this region, the effects of maternal HIV 
and placental malaria on maternal and newborn humoral immunity against influenza, and their 
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potential impact on the efficacy of antenatal influenza vaccination require evaluation. A 
randomised trial of inactivated influenza vaccine in pregnant women found lower 
seroconversion to all vaccine strains in HIV-infected mothers, compared with HIV-uninfected 
mothers, but the efficiency of transplacental antibody transfer was similar [20]. No studies to 
date have evaluated the effect of placental malaria on maternal-fetal transfer of influenza 
antibodies.  
We investigated the effect of maternal HIV infection and placental malaria on influenza 
antibody levels in unvaccinated pregnant women and their newborn in Malawi, a high HIV and 
malaria prevalence setting. 
 
Methods 
 
Study design and setting 
Between January 2013 and February 2014, we undertook a cross-sectional study of mother-
newborn pairs at two sites in southern Malawi: Queen Elizabeth Central Hospital (QECH), a 
tertiary referral government hospital in Blantyre covering an urban and peri-urban population 
of 1.3 million, with a high HIV prevalence (17.8% among adults) [21] and low malaria 
transmission; ii) Chikwawa District Hospital, covering a rural district with high year-round 
transmission of Plasmodium falciparum [22], and a 13.4% HIV prevalence [21]. Antiretroviral 
treatment (ART) coverage among known HIV-infected adults and pregnant women in Malawi 
was around 80% [23]. Sentinel severe acute respiratory illness (SARI) surveillance was 
undertaken in Blantyre [24], but not in Chikwawa during the study period. There is no national 
influenza vaccination programme. 
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 Study Participants 
Pregnant women aged >18 years presenting for delivery were enrolled at the labor ward at the 
two hospitals (see Supplementary Figure 1 for eligibility criteria). Recruitment in Chikwawa 
was conducted as part of a randomized controlled trial (ISTp) that compared the effectiveness 
of scheduled intermittent screening with rapid diagnostic tests (RDT) and treatment with 
dihydroartemisinin-pyrimethamine and intermittent preventative therapy with sulfadoxine-
pyrimethamine to prevent malaria during pregnancy in HIV-negative mothers (ISRCTN 
Registry ISRCTN69800930) [25]. HIV-infected mothers were excluded from the trial. 
Study procedures 
Sample collection and processing 
Maternal venous blood was collected within 12 hours of delivery. Cord blood was collected at 
delivery. Sera (Blantyre) and heparinised plasma (Chikwawa) were separated and stored at -
80°C until analysis.  
HIV status was assessed using sequential rapid tests (Alere Determine HIV-1/2 and Trinity 
Biotech Uni-Gold HIV) [26]. RDT for malaria [Paracheck Pf, Orchid Biomedical Systems, 
Goa, India) was performed as per the manufacturer’s instructions. 
HAI assay was undertaken at the National Institute for Communicable Diseases (NICD) in 
Johannesburg, South Africa. Patient sera and plasma were treated with receptor destroying 
enzyme (Denka Seiken RDE II), then heat-inactivated and diluted. Serial dilutions of sera and 
plasma were incubated with equal volumes of reference antigens A/California/7/2009 
(A(H1N1)pdm09), A/Victoria/361/2011 (A(H3N2), B/Brisbane/60/2008 (B/Victoria-lineage), 
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 7 
and B/Wisconsin/1/2010 (B/Yamagata-lineage) (vaccine strains for Southern and Northern 
Hemispheres during study period); 2012 VIDRL-WHO influenza virus typing kit, 
www.influenzacentre.org) at 4 hemagglutinating units each. After one-hour incubation, an 
equal volume of 0.5% turkey red blood cells was added and left to settle for 45 minutes. Plates 
were visually inspected to determine HAI titers.  Control reagents were included to monitor for 
non-specific agglutination. HAI titer was expressed as the reciprocal of the highest serum 
dilution where heamagglutination was inhibited. HAI titers in sera and plasma were compared 
in a random subset of Blantyre mother-infant pairs. 
After delivery, a standard questionnaire was administered to mothers to collect demographic 
data, pregnancy and childbirth history, and socioeconomic indicators (including maternal 
education, asset ownership, access to sanitation and water facilities, and housing materials). 
Newborn infants were weighed on digital scales; infants weighing <2500 grams were classified 
as low birth weight. Due to poor recall of last menstrual period at the time of delivery and 
limited access to prenatal ultrasound, gestational age of the newborn was assessed using the 
modified Ballard score [27]. Those with a gestational age <37 weeks were classified as preterm. 
A socio-economic index, divided into tertiles, was generated using Principal Components 
Analysis [28]. 
Placental biopsies were collected and fixed in 10% neutral buffered formalin, then processed 
and embedded in paraffin wax. Four micron thin sections were stained with hematoxylin and 
eosin stains. The slides were read for presence of parasitized erythrocytes and hemozoin 
pigment, and categorized as: “active infection” if parasitized erythrocytes were present; 
“chronic infection” if both parasitized erythrocytes and pigmented macrophages were present; 
“past infection” if pigment only was present in fibrin, and “no infection”  if no parasites or 
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 8 
pigment was present [29]. Active and chronic infection were classified as ‘placental malaria-
positive’, while past and no infection were classified as ‘placental malaria-negative’. 
Statistical analysis 
Analysis was stratified by site due to distinct recruitment periods at the two sites 
(Supplementary Figure 2), recruitment of HIV-infected mothers from Blantyre only, and HAI 
measurement from different blood components (serum in Blantyre and plasma in Chikwawa). 
Thus, the impact of maternal HIV infection on maternal-fetal influenza antibody transfer was 
studied within Blantyre mother-infant pairs, while the effect of placental malaria was evaluated 
among Chikwawa mother-infant pairs.  
A previous study in Malawi found a 21% and 18% reduction in placental transfer of IgG 
antibodies to Streptococcus pneumoniae by maternal HIV infection and placental malaria, 
respectively [14]. Assuming that transplacental transfer of influenza antibodies would be 
attenuated by a similar magnitude to that observed in pneumococcal antibodies, a sample size 
of 225 mother-infant pairs per site would provide 80% power to detect a >20% difference in 
the proportion of newborns with HAI titer >1:40 to the four circulating influenza strains. 
Statistical analyses were performed using Stata, version 14.1 (StataCorp LLC, College Station, 
Texas, USA). Baseline characteristics of enrolled mothers and newborns were compared using 
X2 test for categorical data, and Wilcoxon rank sum test for continuous data. Maternal and cord 
HAI titers against influenza A(H1N1)pdm09, A(H3N2), B/Victoria and B/Yamagata viruses 
were logarithmically transformed to calculate geometric mean titers (GMT) and 95% 
confidence intervals (CI). HAI titers <1:10 were assigned a value of 1:5 and those with titers 
>1:1280 were assigned a titer of 1:2560. The primary endpoint was the proportion of infants 
with HAI titers of >1:40 (considered seropositive), which is associated with a >50% reduction 
in symptomatic influenza in young healthy adults [30, 31].  
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 9 
Logistic regression was used to estimate the association of maternal HIV infection and 
placental malaria with infant influenza seropositivity, as well as the role of possible 
confounding covariates, including maternal age, parity, gestational age (<37 or >37 weeks), 
infant birth weight (<2500 or >2500 grams), socioeconomic status, and season of recruitment. 
Multivariable models were built using stepwise backward elimination of covariates with p 
values >0.20. Significant variables were included in the multivariable models for all four 
strains. Maternal HAI titers were considered to be on the causal pathway in the analyses of 
infant HAI seropositivity, hence were excluded from the regression models. Two-sided p-value 
of <0.05 was considered significant.   
Linear regression models were used to investigate the impact of HIV and placental malaria 
infection on the association between log maternal and cord titers, adjusted for any identified 
risk factors for infant seropositivity. The slope of the linear regression line (b1) represents the 
ratio between log cord and maternal HAI titers (cord-maternal ratio), providing an estimate of 
the efficiency of transplacental maternal antibody transfer.  
Ethics statement 
The study was approved by the University of Malawi College of Medicine Research Ethics 
Committee, Blantyr , Malawi. The US Centers for Disease Control and Prevention (CDC) 
reviewed the protocol and relied on the University of Malawi Ethics Committee (CDC 
IRB#6507). Written informed consent was obtained from all participating women. 
 
Results 
Recruitment took place between January and August 2013 in Chikwawa, and between 
September 2013 and February 2014 in Blantyre (Supplementary Figure 2). Overall, 454 
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mother-newborn pairs (Blantyre n=253; Chikwawa n=201); were included in the analysis 
(Supplementary Figure 3, Table 1). The median maternal age was 22 years (interquartile range 
(IQR 19-28). Forty percent of women were primigravid. Thirty-seven of 253 (14.6%) Blantyre 
mothers were HIV positive. Placental malaria was identified in 10 of 214 (4.7%) Blantyre 
women and 63 of 201 (31.3%) Chikwawa women. Only one enrolled mother in Blantyre had 
HIV and placental malaria co-infection. Three of 243 (1.2%) Blantyre mothers and 38 of 200 
(19.1%) Chikwawa mothers had a positive malaria RDT. None of the mothers had received 
influenza vaccination. 
Among the newborns, 224 (49.4%) were males. Median gestational age of the babies was 39 
weeks (range 30-42 weeks). Thirty-five of 448 (7.8%) newborns with available Ballard score 
were preterm. Low birth weight was observed in 36 (7.9%) infants, of whom 17 (48.6%) were 
preterm. 
Influenza antibody titers in mothers and infants, by maternal HIV and placental malaria 
status 
The proportion of mothers and newborns with HAI titers >1:40 against the circulating influenza 
strains and the corresponding GMT by maternal HIV and placental malaria status are shown in 
Supplmentary Tables 1 and 2. Among Blantyre mother-infant pairs, both HIV-infected mothers 
and their newborns had a lower proportion of seropositivity for inﬂuenza A(H1N1)pdm09 and 
A(H3N2), compared to HIV-uninfected mother-infant pairs (Influenza A(H1N1)pdm09: 
mothers, 24.3% vs. 45.4%, p=0.02; infants 24.3% vs. 50.5%, p=0.003. Influenza A(H3N2): 
mothers 37.8% vs. 63.9%, p=0.003; infants 43.2% vs. 64.8%, p=0.01) (Supplementary Table 
1). HIV-infected mothers and their infants also had significantly lower GMTs for HAI 
antibodies for both influenza A strains (GM ratio for influenza A(H1N1)2009 0.59, 95%CI 
0.35-0.99; A(H3N2) 0.45, 95%CI 0.29-0.71). Percentage seropositivity among mother-infant 
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pairs were lower for B/Victoria (8.3-13.5%) and B/Yamagata (11.1-19.9%), with no difference 
by HIV status. 
Among Chikwawa mother-infant pairs, seropostivity to the four different influenza strains 
varied from 66.7-100% among mothers and 66.7-98.6% among infants (Supplementary Table 
2). Placental malaria was associated with lower maternal seropositivity (78.7 vs. 91.1%, 
p=0.02) and GMT (121.7 vs. 239.2; GM ratio 0.51, 95% CI 0.32-0.80) for influenza 
A(H1N1)pdm09, but this difference was not observed in the infants. Placental malaria status 
had no impact on maternal and infant seropositivity for the other influenza strains, though 
mothers with placental malaria and their newborns had lower GMT for B/Victoria compared 
to those without placental malaria (GMT in mothers: 418.7 vs. 663.9; GM ratio 0.63, 95% CI 
0.37-1.06, GMT in infants: 96.0 vs. 150.2, GM ratio 0.64, 95%CI 0.41-1.01). 
In the 34 Blantyre mother-infant pairs that had HAI assay performed on both sera and plasma, 
HAI GMT from plasma were generally higher than the corresponding serum values for all four 
viruses tested, but the difference by blood component was significant for B/Victoria (GMT 
46.6 vs. 9.3, GM ratio 5.01 (2.73-9.18) and B/Yamagata (GMT 233.3 vs. 15.2, GM ratio 15.36 
(8.43-27.98) (Supplementary Table 3).  
Factors associated with infant seropositivity   
Among Blantyre mother-infant pairs, maternal HIV was associated with a significantly lower 
proportion of infants with HAI titer >1:40 for influenza A(H1N1)pdm09 (24.3% vs. 50.5%; 
adjusted odds ratio (aOR) 0.34, 95% CI 0.15-0.79) and A(H3N2) (43.2% vs. 64.8%; OR 0.43, 
95% CI 0.21-0.89) (Table 2). There was no association between maternal HIV and infant 
seropositivity for the influenza B strains. Younger maternal age (<25 years) was associated 
with infant seropositivity for influenza A(H1N1)pdm09 (aOR 2.61, 95%CI 1.54-4.45), and 
influenza B/Yamagata (aOR 1.83, 95%CI 0.97-3.79). Additionally, January to April 
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recruitment was associated with infant seropositivity for influenza A(H1N1)pdm09 (aOR 2.3, 
95%CI 1.34-4.20) and influenza B/Victoria (aOR 2.40, 95% CI 1.13-5.10).  
Placental malaria had no association with infant seropositivity for any of the influenza strains 
in Chikwawa (Table 3). Younger maternal age was associated with infant seropositivity against 
influenza A(H3N2) (71.3 vs. 51.4%; aOR 2.50, 95% 1.18-5.27). Conversely, older maternal 
age was associated with infant seropositivity for influenza B/Victoria (82.2 vs. 94.7%, aOR 
4.29 (0.96-19.16). Recruitment between May and August was associated with increased odds 
of infant seropositivity for influenza B/Victoria. 
Transplacental transfer of maternal influenza antibodies  
Figures 1 and 2 illustrate the relationship between maternal and cord blood HAI titers by 
maternal HIV and placental malaria status, respectively. Among Blantyre mother-infant pairs, 
a strong positive linear relationship between maternal and cord HAI titers was observed for 
influenza A(H1N1)pdm09 (HIV-uninfected mothers: b1=0.825, R2= 0.695; HIV-infected 
mothers: b1=0.810, R2=0.670) and A(H3N2) (HIV-uninfected mothers: b1=0.841, R2= 0.719; 
HIV-infected mothers: b1=0.834, R2=0.672), suggesting efficient transplacental transfer 
(Figure 1 & Supplementary Table 4). In contrast, poor linear association between maternal and 
infant titers was obs rved for B/Victoria and B/Yamagata. The slopes of the regression lines 
between HIV-infected and HIV-uninfected mother-infant pairs were not significantly different 
for all four strains, suggesting that maternal HIV had no impact on transplacental transfer 
(Supplementary Table 4). 
Among Chikwawa mother-infant pairs, some linear association between maternal and cord 
HAI titers against influenza A(H1N1)pdm09 was observed (placental malaria-positive 
mothers, R2=0.456; placental malaria-negative mothers, R2=0.609) and A(H3N2) (placental 
malaria-positive mothers, R2=0.867; placental malaria-negative mothers R2=0.691), but not for 
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B/Victoria and B/Yamagata (Figure 2). The slope of the regression line differed by placental 
malaria status for influenza A(H1N1)pdm09 (placental malaria-positive vs. placental malaria-
negative: b1 0.604 vs. 0.796, p=0.05) and A(H3N2) (placental malaria-positive vs. placental 
malaria-positive: b1 0.970 vs. 0.823, p=0.06) (Supplementary Table 4). There was no 
difference in the slopes of the regression lines for B/Victoria and B/Yamagata by placental 
malaria status. 
 
Discussion 
HIV-infected mothers and their newborns had lower percentage seropositivity and HAI titers 
to influenza A, but not B viruses, compared to HIV-negative mother-infant pairs. Maternal 
HIV infection did not affect transplacental antibody transfer. In contrast, placental malaria had 
no consistent impact on maternal and newborn influenza antibody levels or transplacental 
transfer. Season of recruitment and young maternal age were also independently associated 
with infant seropositivity. 
There are two possible explanations for the lower antibody responses observed in HIV-infected 
mothers: i) HIV-infected mothers generate weaker humoral responses to influenza virus 
infection than moth rs without HIV, and ii) HIV-infected pregnant women avoid crowded 
areas to mitigate infection exposure, and therefore have a lower probability of influenza 
infection. Existing evidence supports the former; an influenza vaccine trial in pregnant women 
found lower antibody responses to all three vaccine strains in HIV-infected mothers, compared 
to HIV-uninfected women [20]. Interestingly, lower HAI titers did not translate to poorer 
clinical efficacy [9]. Infants of HIV-infected mothers also had lower titers, but insufficient 
power precluded evaluation of vaccine efficacy [20]. Second, studies have reported a greater 
burden of symptomatic influenza in adults [17] and pregnant women [18] with HIV infection 
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than those without HIV. Therefore it seems unlikely that HIV-infected mothers in our study 
would have experienced fewer influenza infection than HIV-uninfected women. Furthermore, 
a study exploring the community perceptions of influenza in Malawi did not identify avoidance 
of crowded places as a known strategy to prevent the spread of influenza [32]. We found no 
difference in influenza B/Victoria and B/Yamagata seropositivity by maternal HIV status, 
which we speculate may be due to the comparatively low prevalence of influenza B 
seropositivity among Blantyre mother-infant pairs. 
Malaria infection during pregnancy can affect antibody receptors on the placental surface [33]. 
Several studies have reported reduced transfer of antibodies against measles [14, 33] and 
tetanus [13, 16] in the presence of placental malaria, while others have not [15]. To our 
knowledge, the effect of placental malaria on the transplacental transfer of influenza antibodies 
has not been evaluated. We found no association between placental malaria and infant 
influenza seropositivity. Additionally, placental malaria had no consistent impact on 
transplacental transfer of influenza antibodies; it was associated with less efficient transfer of 
influenza A(H1N1)pdm09 antibodies, but more efficient antibody transfer to A(H3N2). Scott 
et al. found reduced transplacental transfer of measles antibodies only in mothers with active-
chronic placental malaria infection [15]. We classified acute and chronic placental malaria as 
‘positive’ and those with past placental malaria infection as ‘negative’. A sensitivity analysis 
demonstrated no difference in transplacental transfer when placental malaria status was 
stratified as acute, chronic, past, or no infection, except for those with acute infection for 
influenza A/California/7/2009 (Supplementary Figure 4). The observed difference in the slope 
of regression line is not significant since there was no linear relationship between log maternal 
and infant titer (R2=0.033) 
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Infants with mothers aged <25 years had an approximately two-fold increased odds of 
seropositivity against influenza A(H1N1)pdm09 and B/Yamagata in Blantyre, as well as 
A(H3N2) in Chikwawa, compared to infants of older mothers. Young age was also a predictor 
of antibody response in several influenza vaccine studies in HIV-infected and HIV-uninfected 
adults [20, 34]. In HIV-uninfected young individuals, this may be due to better thymic function 
[20]. In HIV-infected adults, poorer antibody response with increasing age may be associated 
with longer duration of HIV infection or, with the former national HIV treatment guidelines 
that recommended commencement of ART at a lower CD4+ threshold, a longer duration of 
HIV-mediated immune dysregulation before ART initiation.  
Influenza seropositivity was high among mothers and their newborns to the influenza A viruses 
in Blantyre, and to all four circulating influenza viruses in Chikwawa. In the context of no 
influenza vaccination coupled with evidence of influenza virus circulation, it is reasonable to 
assume that detected antibodies reflect exposure to natural influenza infection. Seropositivity 
and GMTs varied substantially between Blantyre and Chikwawa mother-infant pairs, 
particularly for influenza B viruses. Although information on circulating influenza strains was 
only available in Blantyre, we postulate that this variability is partly due to exposure to different 
circulating strains from distinct recruitment periods. Moreover, the different blood components 
on which HAI assays were performed is likely a contributory factor. Analysis of paired plasma 
and sera in our subset of Blantyre samples demonstrated significantly higher HAI titers from 
plasma compared to sera for the influenza B viruses, which has been previously reported [35].  
Our study had several limitations. First, because pregnant women were recruited at the time of 
delivery, we were unable to determine maternal history of influenza infection, and could not 
definitively conclude whether low maternal antibody levels was due to poor response to natural 
infection or absence of exposure. Second, CD4+ cell count and ART status of HIV-infected 
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mothers were not captured. Thus we were unable to assess the effect of varying degrees of 
immunosuppression on antibody responses in HIV-infected mothers and infants. Third, 
analysis was stratified by site as a result of the differences in recruitment time periods, blood 
components used for HAI titer, and eligibility criteria (HIV-infected women excluded in 
Chikwawa), thus precluding evaluation of the effect of maternal HIV and placental malaria co-
infection and their potential interaction on transplacental influenza antibody transfer, as only 
one mother from Blantyre had dual infection. Misclassification of prematurity is possible as 
the modified Ballard score is prone to inter-rater variability [36] and tends to overestimate 
gestational age [37]. Lastly, we chose cord HAI titer of >1:40 as a correlate for protection [30, 
31]. Some have argued that higher HAI titers (e.g. 1:110) may be required to provide protection 
against influenza in children due to an immature cellular immune system and a lack of 
immunological memory [38]. Furthermore, a recent study suggested that microneutralization 
(MN) titers may be better predictors of protection compared to HAI [39]. 
In summary, infants of HIV-infected mothers were more likely to be seronegative and have 
lower antibody titers to influenza A viruses, which we postulate is due to an attenuated maternal 
antibody response to natural influenza infection rather than reduced efficiency of placental 
transfer. In contrast, placental malaria had no consistent impact with infant influenza 
seropositivity or transplacental transfer. These findings suggest influenza vaccines targeting 
pregnant women may have variable efficacy in sub-Saharan Africa, where up to 35% of women 
of childbearing age may be HIV-infected [40]. Adjuvanted preparations or higher doses to 
boost maternal antibodies may be required to optimise protection to HIV-infected pregnant 
women and their infants, which will impact on cost-effectiveness of maternal influenza 
immunization interventions. Further studies are needed to define the best correlate of protection 
against influenza disease in HIV-infected persons, and clarify whether the attenuated antibody 
response observed in infants of HIV-infected women results in reduced clinical protection, if 
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it is compounded by dual maternal HIV and placental malaria infection, and whether ART 
improves influenza antibody responses in HIV-infected mothers and infants.  
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Table 1. Demographic and clinical characteristics of enrolled mothers and infants 
 
 
Characteristic 
All Blantyre Chikhwawa 
N=454  
N(%) 
N=253 
N(%) 
N=201  
N(%) 
MATERNAL  
Demographics  
 Age (years) - Median (IQR) 22 (19-28) 25 (19-31) 20 (17–23) 
 Area of residence N=448 N=249 N=199 
  Urban 142 (31.7) 141 (56.6) 0 (0) 
  Peri-urban 67 (15.0) 67 (26.9) 0 (0) 
  Rural 239 (53.3) 41 (16.5) 199 (100) 
 SES index score (tertiles) N=429 N=229 N=200 
  Low  150 (35.0) 17 (7.4) 133 (66.5) 
  Medium  137 (31.9) 73 (31.9) 64 (32.0) 
  High 142 (33.1) 139 (60.7) 3 (1.5)  
Highest level of schooling N=452 N=252 N=202 
  None 33 (7.3) 6 (2.4)  27 (13.5) 
  Primary  269 (59.5) 119 (47.2) 150 (75.0) 
  Secondary 131 (29.0) 108 (42.9) 23 (115)  
  Tertiary 19 (4.2) 19 (7.5) 0 (0) 
 Primigravidae 183 (40.3) 84 (33.2) 99 (49.3)  
Laboratory findings     
  HIV-infected  37 (8.2) 37 (14.6)  0 (0)a  
  Placental malaria  73/415 (17.6) 10/214 (4.7) 63 (31.3) 
  Positive Malaria RDT  41/442 (9.3) 3/243 (1.2) 38/200 (19.1) 
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NEWBORN     
Sex Male 222/440 (49.4) 123/250 (49.2) 99/200 (49.8) 
Gestational Ageb  N=453 N=251 N=197 
  >37 weeks  413 (92.2) 224 (89.2) 189 (95.9) 
  <37 weeks 35 (7.8) 27 (10.6) 8 (4.1) 
Birth weight (grams) Median (IQR) 3000 (2740-3200) 3000 (2800-3240) 3000g (2700-3200) 
 Low birth weight  36/452 (8.0) 23/257 (9.0) 13/200 (6.5) 
Head circumference (cm) Mean (SD) 33.3 ± 2.1  33.0 ± 2.6   33.7 ± 1.3  
Abbreviations: IQR, interquartile range; SES socio-economic status; RDT, rapid diagnostic test; SD, 
standard deviation  
   aHIV-positive women were excluded in Chikwawa study. 
   bBased on Ballard score. 
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Table 2. Association of maternal HIV status and other factors with infant HAI titers >1:40 in 
Blantyre 
 
 HAI titer 
>1:40 
N (%) 
Univariable1  Multivariable2 
OR (95%CI) p-
value 
 aOR (95%CI) p-
value 
A(H1N1) pdm09       
Maternal age (years)       
  18-24 71/121 (58.7) 2.57 (1.55-4.27) <0.001  2.61 (1.54-4.45) <0.001 
  >25 47/132 (35.6) 1   1  
Maternal HIV status       
  Negative 109/216 (50.5) 1   1  
  Positive 9/37 (24.3) 0.32 (0.14-0.70) 0.005  0.34 (0.15-0.79) 0.01 
Season of 
recruitment 
      
  Sep-Dec 70/171 (40.9) 1   1  
  Jan-Apr 48/81 (59.3) 2.10 (1.23-3.59) 0.007  2.38 (1.35-4.20) 0.003 
A(H3N2)       
Maternal age (years)       
  18-24 80/121 (66.1) 1.44 (0.86-2.40) 0.16  1.36 (0.81-2.30) 0.25 
  >25 76/132 (57.6) 1   1  
Maternal HIV status       
  Negative 140/216 (64.8) 1   1  
  Positive 16/37 (43.2) 0.41 (0.20-0.84) 0.02  0.43 (0.21-0.89) 0.02 
Season of 
recruitment 
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Season of 
recruitment 
      
  Sep-Dec 104/171 (60.8) 1   1  
  Jan-Apr 52/81 (64.2) 1.16 (0.67-2.00) 0.61  1.18 (0.67-2.06) 0.56 
B/Victoria       
Maternal age (years)       
  18-24 16/121 (13.2) 1.10 (0.53-2.32) 0.79  1.17 (0.55-2.50) 0.68 
  >25 15/132 (12.1) 1   1  
Maternal HIV status       
  Negative 27/216 (12.5) 1   1  
  Positive 5/37 (13.5) 1.09 (0.39-3.05) 0.86  1.12 (0.39-3.18) 0.84 
Season of 
recruitment 
      
  Sep-Dec 16/171 (9.4) 1   1  
  Jan-Apr 16/81 (19.8) 2.38 (1.13-5.05) 0.02  2.40 (1.13-5.10) 0.02 
B/Yamagata       
Maternal age (years)       
  18-24 30/121 (24.8) 1.85 (0.98-3.47)   1.84 (0.97-3.49) 0.06 
  >25 20/132 (15.2) 1   1  
Maternal HIV status       
  Negative 43/216 (19.9) 1   1  
  Positive 7/37 (18.9) 0.94 (0.39-2.28) 0.89  1.08 (0.44-2.69) 0.86 
Season of 
recruitment 
      
  Sep-Dec 30/171 (17.5) 1   1  
  Jan-Apr 19/81 (23.5) 1.44 (0.75-2.75) 0.27  1.49 (0.77-2.86) 0.23 
Abbreviations: HAI, haemagglutination inhibition; aOR, adjusted odds ratio; CI, confidence interval 
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1Potential confounders assessed: Maternal: age, SES index, parity 
                      Infant: sex, gestational age, birth weight  
                                                     Other: season of recruitment 
2Multivariable logistic regression. Maternal age, maternal HIV status, and season of recruitment   
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Table 3. Association of placental malaria and other factors with infant HAI titers >1:40 in 
Chikwawa 
 HAI titer 
>1:40 
N (%) 
Univariable1  Multivariable2 
OR (95%CI) p-
valu
e 
 aOR (95%CI) p-
valu
e 
A(H1N1) pdm09       
Maternal age (years)       
  18-24 135/158 (85.4) 0.50 (0.14-1.77) 0.29  0.53 (0.15-1.92) 0.34 
  >25 35/38 (92.1) 1   1  
Placental malaria       
  Negative 119/135 (88.2) 1   1  
  Positive 51/61 (83.6) 0.69 (0.29-1.61) 0.39  0.73 (0.31-1.75) 0.48 
Season of 
recruitment 
      
  Jan-Apr 126/145 (86.9) 1.05 (0.42-2.68) 0.91  1.06 (0.41-2.72) 0.90 
  May-Aug 44 (86.3) 1   1  
A(H3N2)       
Maternal age (years)       
  18-24 114/160 (71.3) 2.35 (1.13-4.87) 0.02  2.50 (1.18-5.27) 0.02 
  >25 19/37 (51.4) 1   1  
Placental malaria       
  Negative 91/134 (67.9) 1   1  
  Positive 42/63 (66.7) 0.95 (0.50-1.78) 0.86  0.80 (0.41-1.55) 0.51 
Season of 
recruitment 
      
  Jan-Apr 101/147 (68.7) 1.24 (0.63-2.42) 0.61  1.32 (0.66-2.64) 0.43 
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  May-Aug 32/50 (64.0) 1   1  
B/Victoria       
Maternal age (years)       
  18-24 134/163 (82.2) 1   1  
  >25 36/38 (94.7) 3.90 (0.89-17.10) 0.07  4.29 (0.96-19.16) 0.06 
Placental malaria       
  Negative 118/138 (85.5) 1   1  
  Positive 52/63 (82.5) 0.80 (0.36-1.79) 0.59  1.01 (0.44-2.33) 0.98 
Season of 
recruitment 
      
  Jan-Apr 121/150 (80.7) 1   1  
  May-Aug 49/51 (96.1) 5.87 (1.35-25.56) 0.02  6.27 (1.43-27.48) 0.02 
B/Yamagata       
Maternal age (years)       
  18-24 161/163 (98.8) 2.18 (0.19-24.6) 0.53  2.39 (0.19-29.40) 0.50 
  >25 37/38 (97.4) 1   1  
Placental malaria       
  Negative 136/138 (98.6) 1   1  
  Positive 62/63 (98.4) 0.93 (0.08-10.40) 0.95  0.74 (0.06-9.16) 0.81 
Season of 
recruitment 
      
  Jan-Apr 148/150 (98.7) 1.38 (0.13-16.67) 0.75  1.61 (0.14-18.89) 0.70 
  May-Aug 50/51 (98.0) 1     
Abbreviations: HAI, haemagglutination inhibition; aOR, adjusted odds ratio; CI, confidence interval 
1Potential confounders assessed: Maternal: age, SES index, parity 
                      Infant: sex, gestational age, birth weight  
                                                     Other: season of recruitment 
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2Multivariable logistic regression. Maternal age, placental malaria and season of recruitment were included in 
all multivariable models.
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Figure legends 
 
Figure 1. Relationship between maternal and newborn HAI titers among Blantyre mother-infant pairs, by maternal HIV status                                  
Abbreviations: Ab, antibody; HAI, haemagglutination inhibition 
 
Figure 2. Relationship between maternal and newborn HAI titers among Chikwawa mother-infant pairs, by placental malaria status 
Abbreviations: Ab, antibody; HAI, haemagglutination inhibition
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Figure 1a 
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Figure 1b 
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Figure 1c 
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Figure 1d 
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Figure 2a 
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Figure 2b 
 
 
  
D
ow
nloaded from
 https://academ
ic.oup.com
/ofid/advance-article-abstract/doi/10.1093/ofid/ofz383/5555883 by U
niversity of Liverpool user on 03 Septem
ber 2019
Ac
ce
pte
d M
an
us
cri
pt
 
 39 
Figure 2c 
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Figure 2d 
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